- Home
- KOF vs ITCI Comparison
KOF vs ITCI Comparison
Compare KOF & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOF
- ITCI
- Stock Information
- Founded
- KOF 1979
- ITCI 2002
- Country
- KOF Mexico
- ITCI United States
- Employees
- KOF N/A
- ITCI N/A
- Industry
- KOF Beverages (Production/Distribution)
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- KOF Consumer Staples
- ITCI Health Care
- Exchange
- KOF Nasdaq
- ITCI Nasdaq
- Market Cap
- KOF 16.0B
- ITCI 13.5B
- IPO Year
- KOF 1993
- ITCI N/A
- Fundamental
- Price
- KOF $75.53
- ITCI $126.50
- Analyst Decision
- KOF Strong Buy
- ITCI Buy
- Analyst Count
- KOF 5
- ITCI 13
- Target Price
- KOF $104.75
- ITCI $100.31
- AVG Volume (30 Days)
- KOF 127.7K
- ITCI 4.4M
- Earning Date
- KOF 02-19-2025
- ITCI 02-20-2025
- Dividend Yield
- KOF 4.37%
- ITCI N/A
- EPS Growth
- KOF 2.12
- ITCI N/A
- EPS
- KOF 5.29
- ITCI N/A
- Revenue
- KOF $13,664,366,283.00
- ITCI $613,728,000.00
- Revenue This Year
- KOF $13.32
- ITCI $48.41
- Revenue Next Year
- KOF $9.18
- ITCI $38.26
- P/E Ratio
- KOF $14.40
- ITCI N/A
- Revenue Growth
- KOF 10.54
- ITCI 46.08
- 52 Week Low
- KOF $73.90
- ITCI $62.78
- 52 Week High
- KOF $104.38
- ITCI $128.00
- Technical
- Relative Strength Index (RSI)
- KOF 36.43
- ITCI 85.99
- Support Level
- KOF $75.06
- ITCI $126.16
- Resistance Level
- KOF $77.58
- ITCI $128.00
- Average True Range (ATR)
- KOF 1.71
- ITCI 2.23
- MACD
- KOF 0.02
- ITCI 4.40
- Stochastic Oscillator
- KOF 30.19
- ITCI 96.82
About KOF Coca Cola Femsa S.A.B. de C.V.
Coca-Cola Femsa, a subsidiary of Femsa, is the largest franchise bottler of wide-moat Coca-Cola in volume terms. The company purchases beverage concentrates and syrup from Coca-Cola, which it then processes and packages for distribution through modern trade, traditional trade and the on-premises channel. Mexico and Brazil make up 80% of total sales, with the rest from other Central and South American countries, including Panama, Guatemala, Uruguay, and Argentina. Parent Femsa and Coca-Cola hold 47% and 28% of economic interests in Coca-Cola Femsa, through nonpublicly traded A and D shares, respectively, while controlling 56% and 33% of the respective voting power.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.